Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Catalyst Biosciences, Inc. (CBIO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.7900+0.0100 (+0.56%)
At close: 04:00PM EDT
1.7600 -0.03 (-1.68%)
After hours: 07:57PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.7800
Open1.7500
Bid1.7600 x 3200
Ask1.8100 x 1100
Day's Range1.7500 - 1.8398
52 Week Range0.3500 - 5.2000
Volume915,283
Avg. Volume6,620,921
Market Cap56.223M
Beta (5Y Monthly)1.97
PE Ratio (TTM)N/A
EPS (TTM)-3.0550
Earnings DateMar 02, 2022 - Mar 07, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateAug 20, 2015
1y Target Est11.33
  • GlobeNewswire

    Catalyst Biosciences Announces Plan to Distribute Cash to Stockholders

    Board is Committed to Maximizing the Amount of Cash the Company Distributes to Stockholders Decision Follows Recent Sale of Certain Assets and Extensive Engagement with Stockholders Board Will Set Initial Distribution Date and Amount Once Potential Liability and Expenses Associated with Stockholder Litigation and Proxy Contest Are Known SOUTH SAN FRANCISCO, Calif., June 29, 2022 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) (the “Company” or “we”) today announced its intention to

  • Zacks

    Has Catalyst Biosciences (CBIO) Outpaced Other Medical Stocks This Year?

    Here is how Catalyst Biosciences, Inc. (CBIO) and Humana (HUM) have performed compared to their sector so far this year.

  • American City Business Journals

    The Petri Dish: NIH gives $68M to Pfizer-partnered AI startup

    A roindup of companies developing drugs and devices, inking new partnership deals, raising money, expanding facilities and more.

Advertisement
Advertisement